Shikimic Acid (CAS 138-59-0) Market Size, Share, Growth, and Industry Analysis, By Type (Shikimic Acid (99%), Shikimic Acid (98%)), By Application (Cosmetic, Medicine and Veterinary Drugs), Regional Insights and Forecast to 2035

Shikimic Acid (CAS 138-59-0) Market Overview

Global Shikimic Acid (CAS 138-59-0) Market size is expected to grow from USD 52.07 Million in 2026 to USD 110.92 Million by 2035, registering a steady CAGR of 8.77%.

The Shikimic Acid (CAS 138-59-0) Market is expanding due to increasing utilization of shikimic acid as a pharmaceutical intermediate, biochemical compound, and natural ingredient derived mainly from star anise and botanical sources. Shikimic acid has the molecular formula C7H10O5 and a molecular weight of 174.15 g/mol. The compound is widely recognized as a key precursor for the synthesis of antiviral ingredients, including oseltamivir phosphate. China remains a major production center due to the availability of Illicium verum resources, while extraction technologies have improved purity levels to 98% and 99%. The pharmaceutical sector accounts for a significant portion of global shikimic acid consumption due to rising demand for high-quality active intermediates.

The USA Shikimic Acid (CAS 138-59-0) Market is supported by increasing pharmaceutical research activities and demand for natural bioactive compounds. The United States imports significant quantities of botanical-derived shikimic acid for pharmaceutical applications, with purity requirements commonly reaching 98% for industrial use and 99% for advanced research applications. More than 50 pharmaceutical and biotechnology companies in the country are involved in antiviral development, natural compound research, and biochemical applications. The growing adoption of plant-based ingredients in cosmetics and healthcare formulations has increased interest in shikimic acid. The USA market also benefits from advanced quality control standards, with manufacturers focusing on analytical testing methods such as HPLC analysis for compound verification.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Increasing pharmaceutical demand drives the Shikimic Acid Market, with antiviral-related applications accounting for approximately 65% of total consumption and pharmaceutical manufacturers representing nearly 70% of industrial buyers globally.
• Major Market Restraint: Limited raw material availability affects the Shikimic Acid Market, with approximately 45% dependence on star anise extraction and seasonal agricultural conditions influencing around 35% of supply stability.
• Emerging Trends: Natural ingredient adoption is increasing in the Shikimic Acid Market, with approximately 55% of cosmetic manufacturers showing interest in botanical compounds and nearly 40% of research organizations exploring new applications.
• Regional Leadership: Asia-Pacific dominates the Shikimic Acid Market, accounting for approximately 70% of production capacity, while China contributes nearly 65% of global supply due to established extraction infrastructure.
• Competitive Landscape: The Shikimic Acid Market remains moderately concentrated, with leading manufacturers controlling approximately 60% of production capacity and smaller botanical extraction companies contributing nearly 40% of market supply.
• Market Segmentation: The Shikimic Acid Market is segmented by purity and application, with 99% purity products representing approximately 55% demand and pharmaceutical applications contributing nearly 65% of total consumption.
• Recent Development: Recent manufacturing improvements have increased extraction efficiency by approximately 40%, while advanced purification technologies have improved 99% purity product availability by nearly 30% since 2023.

Latest Trends

The Shikimic Acid (CAS 138-59-0) Market is witnessing increased adoption of natural extraction methods, pharmaceutical-grade purification, and biotechnology-based applications. The demand for high-purity shikimic acid has increased because pharmaceutical manufacturers require consistent quality for active ingredient synthesis. Products with 99% purity are increasingly preferred in research laboratories and pharmaceutical applications due to stricter quality requirements. The global interest in plant-derived compounds has also expanded the role of shikimic acid in cosmetic formulations, where approximately 35% of new natural ingredient developments focus on botanical sources. Manufacturers are investing in improved extraction technologies to reduce impurities and increase production efficiency. Modern purification systems using chromatography and crystallization techniques have improved compound stability by approximately 30%. Asia-Pacific continues to dominate production because star anise cultivation remains concentrated in China and Vietnam. The increasing use of analytical methods such as high-performance liquid chromatography ensures accurate identification and quality verification of shikimic acid. The veterinary pharmaceutical sector is also creating additional opportunities, with approximately 20% of emerging applications linked to animal healthcare research. B

Market Dynamics

The Shikimic Acid (CAS 138-59-0) Market is influenced by pharmaceutical demand, natural ingredient trends, extraction technology improvements, and changing regulatory requirements. The compound’s importance as a biochemical precursor continues to support market expansion. Pharmaceutical companies rely on high-quality shikimic acid for antiviral synthesis, while cosmetic manufacturers are increasing adoption of natural active ingredients. Production capabilities are concentrated in Asia-Pacific, making supply chain efficiency a major factor affecting global availability.

DRIVER

Rising demand for pharmaceutical intermediates and antiviral research.

The rising demand from pharmaceutical manufacturers is the leading driver of the Shikimic Acid (CAS 138-59-0) Market. Shikimic acid is widely recognized as a critical precursor in the synthesis of pharmaceutical compounds, particularly antiviral-related ingredients. Approximately 65% of market consumption is connected to medicine-related applications due to its importance in drug manufacturing processes. Pharmaceutical companies require consistent availability of high-purity shikimic acid, especially 99% purity products, for research and production activities. The expansion of pharmaceutical research programs has increased demand for reliable biochemical intermediates. More than 50 major pharmaceutical and biotechnology organizations globally are involved in antiviral research and natural compound studies. The growing focus on advanced drug development has encouraged manufacturers to improve extraction efficiency and purification capabilities. The increasing adoption of natural compounds in healthcare is another important growth factor. Approximately 55% of pharmaceutical researchers consider plant-derived compounds valuable sources for developing new active ingredients. Shikimic acid benefits from this trend because it is naturally extracted from botanical sources, particularly star anise.

RESTRAINT

Dependence on agricultural raw material availability.

The major restraint affecting the Shikimic Acid Market is dependence on botanical sources, particularly star anise. Approximately 70% of commercially produced shikimic acid is derived from Illicium verum because this plant contains naturally occurring shikimic acid concentrations suitable for extraction. Dependence on agricultural resources creates supply challenges caused by weather conditions, crop availability, and seasonal variations. The concentration of production in specific geographic regions creates additional supply risks. China contributes approximately 65% of global production capacity, making international supply chains dependent on Chinese manufacturing infrastructure. Any disruption affecting agricultural output or processing facilities can influence global availability. Extraction complexity is another significant challenge. Producing pharmaceutical-grade shikimic acid requires multiple processing steps, including extraction, filtration, purification, and crystallization. Approximately 40% of manufacturing activities involve quality control and purification procedures to achieve required purity standards. These processes require specialized equipment, skilled personnel, and strict monitoring systems. The cost associated with maintaining high-purity production facilities can limit market participation for smaller manufacturers.

OPPORTUNITY

Expansion of biotechnology-based production methods.

The Shikimic Acid (CAS 138-59-0) Market has significant opportunities through biotechnology innovation, sustainable production methods, and expanding applications beyond pharmaceutical manufacturing. Researchers are increasingly exploring microbial fermentation as an alternative method for producing shikimic acid. Approximately 30% of current research activities focus on developing biological production systems that can improve consistency and reduce dependence on agricultural resources. Biotechnology-based manufacturing could help address raw material limitations by creating controlled production environments. Companies developing engineered microorganisms and fermentation technologies may improve production efficiency and supply stability. Approximately 25% of biotechnology research investments related to natural compounds focus on improving sustainable synthesis methods. The cosmetic industry provides another growth opportunity. Approximately 20% of shikimic acid demand is connected with cosmetic applications, and this segment is supported by increasing consumer preference for natural skincare ingredients. Cosmetic manufacturers are exploring shikimic acid for formulations containing botanical active compounds, antioxidants, and skin-conditioning ingredients.

CHALLENGE

Complex extraction and purification processes.

The Shikimic Acid Market faces several challenges related to supply chain management, production consistency, and technological limitations. The dependence on botanical raw materials creates uncertainty because agricultural factors directly influence production capacity. Approximately 70% of commercial shikimic acid supply depends on plant extraction, making raw material management a critical challenge. Maintaining consistent quality across different production batches is another important issue. Natural extraction methods can result in variations in compound concentration, requiring advanced purification and testing processes. Approximately 40% of manufacturing operations involve quality control activities to ensure compliance with pharmaceutical requirements. The availability of high-purity products remains challenging for some applications. Pharmaceutical companies require 99% purity shikimic acid, while maintaining such standards requires advanced equipment and technical expertise. Approximately 55% of pharmaceutical buyers demand detailed analytical verification before purchasing. Technological limitations also affect market development. Although fermentation-based production methods show potential, commercial adoption remains limited because approximately 30% of research projects are still focused on improving scalability and production efficiency.

Segmentation Analysis

The Shikimic Acid (CAS 138-59-0) Market is segmented based on purity type and application area. By type, the market includes Shikimic Acid (99%) and Shikimic Acid (98%), with purity requirements varying according to end-use industries. The 99% purity segment is mainly used in pharmaceutical research and advanced applications, while 98% purity products serve industrial and general biochemical requirements. By application, the market includes cosmetics, medicine, and veterinary drugs. Medicine applications represent approximately 65% of consumption due to the role of shikimic acid as a pharmaceutical precursor. Cosmetic applications contribute approximately 20% of demand, while veterinary drugs represent approximately 15% of usage.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Shikimic Acid (99%): Shikimic Acid (99%) represents the premium purity category and is widely preferred in pharmaceutical and biotechnology applications. This segment accounts for approximately 55% of the total Shikimic Acid (CAS 138-59-0) Market demand because pharmaceutical manufacturers require high-quality raw materials for precise synthesis processes. The 99% purity grade undergoes advanced purification procedures, including chromatography and crystallization, to reduce impurities and improve consistency. Research institutions commonly select 99% purity products for analytical studies, biochemical experiments, and pharmaceutical development. Approximately 70% of pharmaceutical-related shikimic acid applications require high-purity material because contamination risks can affect synthesis performance. Increasing investment in drug discovery and natural compound research continues to support demand for 99% purity shikimic acid.

Shikimic Acid (98%): Shikimic Acid (98%) is an important commercial-grade segment used across industrial applications, research activities, and selected pharmaceutical processes. This category represents approximately 45% of market consumption due to its balance between quality requirements and production efficiency. The 98% purity grade is widely utilized in applications where ultra-high purity is not mandatory, including biochemical studies, cosmetic ingredient development, and intermediate manufacturing. Manufacturers produce 98% shikimic acid through optimized extraction and purification methods that provide consistent chemical characteristics. Approximately 40% of cosmetic and research-oriented applications utilize 98% purity products because they provide suitable performance for formulation and testing processes. Demand for this segment continues to increase as companies seek cost-effective natural compounds.

By Application

Cosmetic: The cosmetic application segment is gaining importance in the Shikimic Acid Market due to increasing consumer preference for natural and botanical-based skincare ingredients. Cosmetic applications represent approximately 20% of total shikimic acid demand. The compound is investigated for antioxidant properties, skin-conditioning benefits, and potential applications in advanced skincare formulations. Approximately 35% of new cosmetic ingredient research projects focus on naturally derived compounds, supporting interest in shikimic acid-based formulations. Manufacturers are exploring its use in creams, serums, and specialized skincare products. Growing demand for clean-label cosmetic ingredients and plant-based formulations is encouraging cosmetic companies to evaluate shikimic acid as a functional ingredient.

Medicine: Medicine is the leading application segment in the Shikimic Acid (CAS 138-59-0) Market, accounting for approximately 65% of total consumption. Shikimic acid is primarily valued as a precursor for antiviral pharmaceutical synthesis. Pharmaceutical manufacturers require reliable supply chains and high-purity products to support drug production processes. Approximately 70% of pharmaceutical buyers prioritize purity levels of 99% because of strict quality requirements. Increasing pharmaceutical research activities, expanding antiviral studies, and demand for biochemical intermediates continue to strengthen this segment. Research organizations are also investigating additional therapeutic applications of shikimic acid derivatives, supporting long-term development opportunities in medicine.

Veterinary Drugs: The veterinary drug application segment contributes approximately 15% of the Shikimic Acid Market and is emerging as a developing area. Veterinary pharmaceutical companies are researching natural biochemical compounds for animal healthcare applications. Approximately 20% of new veterinary research activities involve plant-derived active ingredients due to increasing interest in alternative pharmaceutical solutions. Shikimic acid is evaluated as an intermediate in veterinary drug development and biochemical studies. Improvements in animal healthcare research infrastructure and rising demand for advanced veterinary formulations are creating opportunities for market participants. The segment is expected to gain attention as manufacturers explore broader applications of natural compounds.

Regional Outlook

The regional performance of the Shikimic Acid (CAS 138-59-0) Market is influenced by raw material availability, pharmaceutical manufacturing capabilities, and biotechnology development. Asia-Pacific dominates global production due to extensive star anise cultivation and established extraction facilities. North America demonstrates strong demand because of pharmaceutical research activities, while Europe focuses on high-quality natural ingredients and regulatory-compliant production. The Middle East & Africa region represents an emerging market supported by increasing healthcare investment and research activities. Asia-Pacific contributes approximately 70% of global production capacity, making it the leading region for shikimic acid manufacturing.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America represents a significant consumption region in the Shikimic Acid (CAS 138-59-0) Market due to advanced pharmaceutical infrastructure and biotechnology research capabilities. The region accounts for approximately 20% of global market demand, supported by strong pharmaceutical and healthcare industries. The United States is the primary contributor, with more than 50 pharmaceutical and biotechnology companies involved in antiviral research, biochemical development, and natural compound studies. Demand in North America is mainly driven by pharmaceutical applications, which represent approximately 65% of regional consumption. High-purity shikimic acid products with 99% concentration are preferred by research organizations and pharmaceutical manufacturers because of strict quality requirements. The region also demonstrates increasing interest in cosmetic applications, with approximately 30% of natural ingredient research projects focusing on plant-derived compounds. Advanced analytical technologies, including HPLC testing and molecular analysis systems, are widely adopted to ensure product quality. Approximately 40% of North American buyers prioritize suppliers offering advanced quality certification and consistent purity standards.

Europe

Europe accounts for approximately 15% of global Shikimic Acid (CAS 138-59-0) Market demand and represents an important region for pharmaceutical research, cosmetic applications, and biotechnology innovation. Countries including Germany, France, and Switzerland contribute significantly due to established pharmaceutical industries and advanced research facilities. The European market is characterized by strong demand for high-quality natural ingredients and strict quality standards. Pharmaceutical applications contribute approximately 60% of regional consumption because companies require reliable intermediates for biochemical production. Cosmetic applications represent approximately 25% of demand due to increasing consumer interest in botanical skincare products. European manufacturers and research organizations emphasize sustainable sourcing and environmentally responsible production methods. Approximately 35% of new cosmetic formulation research projects focus on natural ingredients, creating additional opportunities for shikimic acid suppliers. Regulatory compliance and quality verification remain major purchasing factors, with many buyers requiring detailed analytical testing. The region continues to invest in biotechnology research, with approximately 30% of emerging studies exploring sustainable alternatives for natural compound production.

Asia-Pacific

Asia-Pacific is the leading region in the Shikimic Acid (CAS 138-59-0) Market, accounting for approximately 70% of global production capacity. China dominates regional manufacturing due to extensive star anise cultivation, established extraction facilities, and experienced botanical processing companies. The region benefits from favorable raw material availability and large-scale production infrastructure. China contributes approximately 65% of global shikimic acid supply, making it the primary exporter to pharmaceutical markets worldwide. The availability of Illicium verum resources supports cost-efficient extraction processes and consistent production volumes. Approximately 60% of regional manufacturers specialize in botanical extraction and purification technologies. Japan, South Korea, and India are also increasing participation through pharmaceutical research and biotechnology applications. Medicine-related applications represent approximately 70% of Asia-Pacific consumption due to strong pharmaceutical manufacturing activity. Cosmetic applications contribute approximately 20% as regional demand for natural skincare ingredients continues expanding. Investments in advanced purification technology have improved production quality, with many manufacturers offering 98% and 99% purity grades.

Middle East & Africa

The Middle East & Africa Shikimic Acid (CAS 138-59-0) Market is an emerging region supported by increasing healthcare development, pharmaceutical imports, and biotechnology research activities. The region contributes approximately 5% of global shikimic acid demand, with pharmaceutical applications representing nearly 60% of regional consumption. Countries such as Saudi Arabia, the United Arab Emirates, and South Africa are improving healthcare infrastructure, which is increasing interest in advanced pharmaceutical intermediates and natural compounds. The pharmaceutical sector remains the primary consumer of shikimic acid in the region because manufacturers require biochemical ingredients for research and production activities. Approximately 40% of regional demand is associated with pharmaceutical research institutions and healthcare-related industries. The growing adoption of natural ingredients in personal care products has also supported cosmetic applications, which account for approximately 25% of regional consumption. The Middle East & Africa region relies significantly on imports from Asia-Pacific producers because local botanical extraction capacity remains limited. Approximately 70% of shikimic acid used in the region is supplied through international trade channels.

List of Top Shikimic Acid (CAS 138-59-0) Companies

• Sanofi
• Layn Natural Ingredients
• JIAHERB
• Shaanxi Huike Botanical
• Xi'an Hao Tian
• Guangxi Wanshan Spice
• JF NATURAL
• Wuhan Dahua Weiye

Top 2 Companies Market Share

• Sanofi – Sanofi represents one of the significant pharmaceutical participants connected with shikimic acid utilization, contributing approximately 15% of demand associated with pharmaceutical-grade applications due to its global drug development activities.
• Layn Natural Ingredients – Layn Natural Ingredients holds approximately 10% market influence in the botanical ingredient sector due to its large-scale plant extraction capabilities and focus on natural compound production.

Investment Analysis and Opportunities

Investment opportunities in the Shikimic Acid (CAS 138-59-0) Market are primarily focused on extraction technology, biotechnology production methods, pharmaceutical applications, and high-purity manufacturing capabilities. Companies investing in advanced purification systems can improve product quality and meet increasing pharmaceutical requirements. Approximately 55% of pharmaceutical users prefer 99% purity shikimic acid, creating opportunities for manufacturers specializing in premium-grade production. Biotechnology-based production represents a significant investment opportunity because approximately 30% of current research activities are focused on alternative synthesis methods. Microbial fermentation and engineered biological systems are being studied to reduce dependence on agricultural sources. These technologies may improve supply stability and create sustainable production pathways. The cosmetic industry also provides investment potential, with approximately 35% of new skincare ingredient research projects focusing on natural compounds. Manufacturers developing customized shikimic acid formulations for cosmetic applications can access expanding demand from clean-label product developers. Asia-Pacific remains the most attractive manufacturing investment region because approximately 70% of global production capacity is located there.

New Product Development

New product development in the Shikimic Acid (CAS 138-59-0) Market is focused on improving purity, sustainability, and application-specific formulations. Manufacturers are developing pharmaceutical-grade shikimic acid products with enhanced consistency, especially 99% purity materials required for advanced applications. Approximately 55% of pharmaceutical users prefer high-purity grades because of strict manufacturing requirements. Advanced extraction methods are being introduced to improve efficiency and reduce processing complexity. Modern purification technologies, including chromatography and crystallization methods, have improved product quality by approximately 30%. These developments enable manufacturers to provide stable compounds suitable for pharmaceutical research, biotechnology applications, and laboratory analysis. Biotechnology companies are exploring fermentation-based shikimic acid production as an alternative to traditional botanical extraction. Approximately 30% of research initiatives are focused on sustainable biochemical manufacturing approaches. These technologies aim to improve scalability and reduce dependency on seasonal agricultural resources. Cosmetic ingredient development is another important innovation area. Approximately 25% of new product concepts involve natural active ingredients designed for skincare and personal care applications.

Five Recent Developments (2023-2025)

• 2023 – Improved Extraction Technology Adoption: Several botanical ingredient manufacturers introduced improved extraction processes that increased shikimic acid recovery efficiency by approximately 30% while maintaining high purity standards.
• 2023 – Expansion of Botanical Processing Capacity: Asian manufacturers expanded production facilities to support increasing demand, with approximately 40% of new capacity focused on pharmaceutical-grade natural compounds.
• 2024 – Development of Sustainable Production Research: Biotechnology companies increased research activities related to microbial fermentation methods, with approximately 30% of studies focusing on alternative shikimic acid production approaches.
• 2024 – Growth in High-Purity Product Availability: Manufacturers increased availability of 99% purity shikimic acid products, supporting pharmaceutical research organizations requiring advanced-quality ingredients.
• 2025 – Increased Application Research: Companies expanded studies on cosmetic and veterinary applications, with approximately 25% of emerging research projects exploring new uses beyond traditional pharmaceutical applications.

Report Coverage

The Shikimic Acid (CAS 138-59-0) Market report covers market structure, production analysis, application trends, regional performance, competitive landscape, and future opportunities. The report evaluates major product categories, including Shikimic Acid (99%) and Shikimic Acid (98%), which together represent the primary commercial forms available globally. The coverage includes analysis of key applications such as cosmetics, medicine, and veterinary drugs. Medicine remains the dominant segment, contributing approximately 65% of market consumption due to pharmaceutical demand for shikimic acid as a biochemical precursor. Cosmetic applications represent approximately 20% of demand, supported by increasing interest in natural ingredients. Regional analysis covers North America, Europe, Asia-Pacific, and the Middle East & Africa. Asia-Pacific leads production with approximately 70% of global manufacturing capacity, while North America and Europe represent important consumption markets due to pharmaceutical and biotechnology activities. The report also examines leading companies, including Sanofi, Layn Natural Ingredients, JIAHERB, Shaanxi Huike Botanical, Xi'an Hao Tian, Guangxi Wanshan Spice, JF NATURAL, and Wuhan Dahua Weiye. Competitive evaluation focuses on production capabilities, product quality, application focus, and innovation strategies.

Shikimic Acid (CAS 138-59-0) Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 52.07 Billion in 2026
Market Size Value By	USD 110.92 Billion by 2035
Growth Rate	CAGR of 8.77% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Shikimic Acid (99%) Shikimic Acid (98%) By Application : Cosmetic Medicine and Veterinary Drugs
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample